Alexander-Savino, Carolina V. http://orcid.org/0000-0002-3830-7097
Mirowski, Ginat W. http://orcid.org/0000-0003-3146-4871
Culton, Donna A. http://orcid.org/0000-0002-7692-6446
Article History
Accepted: 4 December 2023
First Online: 13 January 2024
Declarations
:
: No funding was received for the preparation of this article.
: Carolina V. Alexander-Savino has no conflicts of interest that are directly relevant to the content of this article. Donna A. Culton has received fees from Argenx for serving on advisory boards, serves as a principal investigator in clinical trials for Regeneron, Cabaletta, and Incyte, and receives royalties from UpToDate. Ginat W. Mirowski receives royalties from UpToDate.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: CVA, GWM, and DAC contributed to the literature review and writing of the manuscript. All authors have read and approved the final version of the manuscript and agree to be accountable for the work as presented.